Support for Fourth COVID-19 Jab in Blood Cancer Patients
For patients with blood cancer, three doses of COVID-19 vaccine may not generate detectable neutralizing antibodies against the Omicron variant of SARS-CoV-2, according to a new study from the UK.
Reuters Health Information
source https://www.medscape.com/viewarticle/967832?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/967832?src=rss
Comments
Post a Comment